{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:11:49Z","timestamp":1792606309286,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T00:00:00Z","timestamp":1505347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s40261-017-0568-2","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T15:10:42Z","timestamp":1505401842000},"page":"1083-1091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial"],"prefix":"10.1007","volume":"37","author":[{"given":"Rituparna","family":"Maiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Sekhar","family":"Sirka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Ashique Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sansita","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasish","family":"Hota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"issue":"2","key":"568_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00128071-200304020-00001","volume":"4","author":"LE Millikan","year":"2003","unstructured":"Millikan LE. The rationale for using a topical retinoid for inflammatory acne. Am J Clin Dermatol. 2003;4(2):75\u201380.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"568_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1523-1747.2003.12321.x","volume":"121","author":"AH Jeremy","year":"2003","unstructured":"Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121(1):20\u20137.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"568_CR3","first-page":"582","volume":"6","author":"T Rosen","year":"2007","unstructured":"Rosen T. The Propionibacterium acnes genome: from the laboratory to the clinic. J Drugs Dermatol. 2007;6(6):582\u20136.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"568_CR4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jaad.2007.12.024","volume":"58","author":"TT Do","year":"2008","unstructured":"Do TT, Zarkhin S, Orringer JS, Nemeth S, Hamilton T, Sachs D, et al. Computer-assisted alignment and tracking of acne lesions indicate that most inflammatory lesions arise from comedones and de novo. J Am Acad Dermatol. 2008;58(4):603\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"568_CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1517\/17425250902721250","volume":"5","author":"R Talpur","year":"2009","unstructured":"Talpur R, Cox K, Duvic M. Efficacy and safety of topical tazarotene: a review. Expert Opin Drug Metab Toxicol. 2009;5(2):195\u2013210.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"568_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1468-3083.1998.tb00974.x","volume":"11","author":"JR Richter","year":"1998","unstructured":"Richter JR, Forstrom LR, Kiistala UO, Jung EG. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne. J Eur Acad Dermatol Venereol. 1998;11(3):227\u201333.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"568_CR7","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1468-3083.1998.tb00903.x","volume":"11","author":"F Cambazard","year":"1998","unstructured":"Cambazard F. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris. J Eur Acad Dermatol Venereol. 1998;11(Suppl 1):S20\u20137 (discussion S8\u2013S9).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"568_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2005.04.046","volume":"54","author":"JJ Leyden","year":"2006","unstructured":"Leyden JJ, Krochmal L, Yaroshinsky A. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin\/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris. J Am Acad Dermatol. 2006;54(1):73\u201381.","journal-title":"J Am Acad Dermatol"},{"issue":"5 Suppl","key":"568_CR9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","volume":"60","author":"D Thiboutot","year":"2009","unstructured":"Thiboutot D, Gollnick H, Bettoli V, Dreno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"2 Suppl","key":"568_CR10","first-page":"20","volume":"69","author":"ZD Draelos","year":"2002","unstructured":"Draelos ZD, Tanghetti EA, Tazarotene Combination Leads to Efficacious Acne Results (CLEAR) Trial Study Group. Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy. Cutis. 2002;69(2 Suppl):20\u20139.","journal-title":"Cutis"},{"issue":"4","key":"568_CR11","first-page":"621","volume":"3","author":"S Piskin","year":"2007","unstructured":"Piskin S, Uzunali E. A review of the use of adapalene for the treatment of acne vulgaris. Ther Clin Risk Manag. 2007;3(4):621\u20134.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"568_CR12","first-page":"8","volume":"69","author":"SK Dos","year":"2003","unstructured":"Dos SK, Barbhuiya JN, Jana S, Dey SK. Comparative evaluation of clindamycin phosphate 1% and clindamycin phosphate 1% with nicotinamide gel 4% in the treatment of acne vulgaris. Indian J Dermatol Venereol Leprol. 2003;69(1):8\u20139.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"568_CR13","first-page":"153","volume":"4","author":"A Shalita","year":"2005","unstructured":"Shalita A, Miller B, Menter A, Abramovits W, Loven K, Kakita L. Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. J Drugs Dermatol. 2005;4(2):153\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"2 Suppl","key":"568_CR14","first-page":"4","volume":"69","author":"GF Webster","year":"2002","unstructured":"Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. Cutis. 2002;69(2 Suppl):4\u201311.","journal-title":"Cutis"},{"issue":"4","key":"568_CR15","first-page":"438","volume":"12","author":"SR Feldman","year":"2013","unstructured":"Feldman SR, Werner CP, Alio Saenz AB. The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies. J Drugs Dermatol. 2013;12(4):438\u201346.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"568_CR16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-4362.1997.00099.x","volume":"36","author":"A Doshi","year":"1997","unstructured":"Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36(6):416\u20138.","journal-title":"Int J Dermatol"},{"issue":"3","key":"568_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0378-6323.51258","volume":"75","author":"B Adityan","year":"2009","unstructured":"Adityan B, Kumari R, Thappa DM. Scoring systems in acne vulgaris. Indian J Dermatol Venereol Leprol. 2009;75(3):323\u20136.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"568_CR18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2230.2001.00839.x","volume":"26","author":"AR Martin","year":"2001","unstructured":"Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ. Health-related quality of life among patients with facial acne\u2014assessment of a new acne-specific questionnaire. Clin Exp Dermatol. 2001;26(5):380\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"568_CR19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00540020","volume":"5","author":"CJ Girman","year":"1996","unstructured":"Girman CJ, Hartmaier S, Thiboutot D, Johnson J, Barber B, DeMuro-Mercon C, et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res. 1996;5(5):481\u201390.","journal-title":"Qual Life Res"},{"issue":"8","key":"568_CR20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1023\/A:1020880005846","volume":"11","author":"SE Fehnel","year":"2002","unstructured":"Fehnel SE, McLeod LD, Brandman J, Arbit DI, McLaughlin-Miley CJ, Coombs JH, et al. Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res. 2002;11(8):809\u201316.","journal-title":"Qual Life Res"},{"issue":"6 Suppl","key":"568_CR21","first-page":"s18","volume":"7","author":"D Pariser","year":"2008","unstructured":"Pariser D, Colon LE, Johnson LA, Gottschalk RW. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris. J Drugs Dermatol. 2008;7(6 Suppl):s18\u201323.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"568_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D30N81Z2H4","volume":"13","author":"E Tanghetti","year":"2007","unstructured":"Tanghetti E, Dhawan S, Torok H, Kircik L. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris. Dermatol Online J. 2007;13(3):1.","journal-title":"Dermatol Online J"},{"issue":"3 Suppl","key":"568_CR23","first-page":"S211","volume":"49","author":"JE Wolf Jr","year":"2003","unstructured":"Wolf JE Jr, Kaplan D, Kraus SJ, Loven KH, Rist T, Swinyer LJ, et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study. J Am Acad Dermatol. 2003;49(3 Suppl):S211\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"568_CR24","first-page":"22","volume":"4","author":"JJ Leyden","year":"2011","unstructured":"Leyden JJ, Preston N, Osborn C, Gottschalk RW. In-vivo Effectiveness of adapalene 0.1%\/benzoyl peroxide 2.5% gel on antibiotic-sensitive and resistant Propionibacterium acnes. J Clin Aesthet Dermatol. 2011;4(5):22\u20136.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"11","key":"568_CR25","first-page":"22","volume":"4","author":"N Schmidt","year":"2011","unstructured":"Schmidt N, Gans EH. Tretinoin: a review of its anti-inflammatory properties in the treatment of acne. J Clin Aesthet Dermatol. 2011;4(11):22\u20139.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"568_CR26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.clindermatol.2004.03.013","volume":"22","author":"D Rigopoulos","year":"2004","unstructured":"Rigopoulos D, Ioannides D, Kalogeromitros D, Katsambas AD. Comparison of topical retinoids in the treatment of acne. Clin Dermatol. 2004;22(5):408\u201311.","journal-title":"Clin Dermatol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-017-0568-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T21:22:06Z","timestamp":1659475326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-017-0568-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1007\/s40261-017-0568-2","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,14]]}}}